[
  {
    "ts": "2025-09-16T13:00:00+00:00",
    "headline": "ClostraBio Announces Key Milestones: Board Appointment of Industry Veteran Scott Ravech and Publication of CLB101™ Safety Data",
    "summary": "CHICAGO, September 16, 2025--ClostraBio, Inc., a biotech company pioneering microbiome-based solutions for gastrointestinal health, today announced two major milestones: the appointment of Scott Ravech, former CEO of Deerland Probiotics & Enzymes, to its Board of Directors, and the peer-reviewed publication of toxicology data validating the safety of its lead ingredient, Anaerostipes caccae CLB101™. These achievements set the stage for the company’s commercial launch later this month with a lead",
    "url": "https://finance.yahoo.com/news/clostrabio-announces-key-milestones-board-130000024.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2eef6e5f-d89a-395f-9fe1-1086dcebcdf4",
      "content": {
        "id": "2eef6e5f-d89a-395f-9fe1-1086dcebcdf4",
        "contentType": "STORY",
        "title": "ClostraBio Announces Key Milestones: Board Appointment of Industry Veteran Scott Ravech and Publication of CLB101™ Safety Data",
        "description": "",
        "summary": "CHICAGO, September 16, 2025--ClostraBio, Inc., a biotech company pioneering microbiome-based solutions for gastrointestinal health, today announced two major milestones: the appointment of Scott Ravech, former CEO of Deerland Probiotics & Enzymes, to its Board of Directors, and the peer-reviewed publication of toxicology data validating the safety of its lead ingredient, Anaerostipes caccae CLB101™. These achievements set the stage for the company’s commercial launch later this month with a lead",
        "pubDate": "2025-09-16T13:00:00Z",
        "displayTime": "2025-09-16T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3b14ad098c0812729e7d597294262786",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vikBtV3pdzx7dCLstv5a_Q--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3b14ad098c0812729e7d597294262786.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nfDmJo05mN5CGSXENdauzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3b14ad098c0812729e7d597294262786.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/clostrabio-announces-key-milestones-board-130000024.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/clostrabio-announces-key-milestones-board-130000024.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ADM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]